#subpotent-drug
FDA classifies levothyroxine recall over subpotency
The FDA has classified a nationwide levothyroxine recall involving select Major Pharmaceuticals tablets after potency testing found some lots contained less active ingredient than required. The action covers multiple strengths and package sizes used for thyroid treatment. Nationwide levothyroxine recall The U.S. Food and Drug Administration has classified a nationwide recall involving select lo
FDA classifies levothyroxine recall over subpotency
The FDA has classified a nationwide levothyroxine recall involving select Major Pharmaceuticals tablets after potency testing found some lots contained less active ingredient than required. The action covers multiple strengths and package sizes used for thyroid treatment. Nationwide levothyroxine recall The U.S. Food and Drug Administration has classified a nationwide recall involving select lo









